Monday June 26th 2017

Archive for June, 2014

[Regarding the article: "multiple sclerosis treatment with natalizumab: analysis of a hospital-based cohort"].

[Regarding the article: "multiple sclerosis treatment with natalizumab: analysis of a hospital-based cohort"].

. Acta Med Port. 2014 Jul-Aug;27(4):409-10 Authors: de Sá J PMID: 25203944 (Source: Acta Medica Portuguesa) [Read More]

Multiple sclerosis treatment with natalizumab: analysis of a hospital-based cohort.

Multiple sclerosis treatment with natalizumab: analysis of a hospital-based cohort.

CONCLUSION: Our study confirms natalizumab efficacy and safety in the treatment of relapsing-remitting multiple sclerosis in a 'realworld' practice. PMID: 25203951 (Source: Acta Medica Portuguesa)MedWorm Sponsor Message: Find the best Christmas Sales, Boxing Day Sales and [Read More]

Functional outcomes associated with expiratory muscle strength training: Narrative review.

Functional outcomes associated with expiratory muscle strength training: Narrative review.

Authors: Laciuga H, Rosenbek JC, Davenport PW, Sapienza CM Abstract This review presents the available evidence for the effects of expiratory muscle strength training (EMST) with the use of a pressure threshold device. The investigators used computerized database searches [Read More]

 Page 1 of 99  1  2  3  4  5 » ...  Last » 

Latest Topics

Are static and functional balance abilities related in individuals with Multiple Sclerosis? – Pau M, Porta M, Coghe G, Corona F, Pilloni G, Lorefice…

Are static and functional balance abilities related in individuals with Multiple Sclerosis? – Pau M, Porta M, Coghe G, Corona F, Pilloni G, Lorefice…

BACKGROUND: In people with Multiple Sclerosis (pwMS), balance assessment is essential in estimating the risk of falls, [Read More]

CHMP Recommends Cladribine (Mavenclad) for Multiple Sclerosis CHMP Recommends Cladribine (Mavenclad) for Multiple Sclerosis

CHMP Recommends Cladribine (Mavenclad) for Multiple Sclerosis CHMP Recommends Cladribine (Mavenclad) for Multiple Sclerosis

The European Medicines Agency ’ s Committee for Medicinal Products for Human Use recommends approval of cladribine to [Read More]

Germany’s Merck gets EU backing for oral MS drug

Germany’s Merck gets EU backing for oral MS drug

FRANKFURT (Reuters) - Germany's Merck KGaA has won a key recommendation to become a late entrant to the market for oral [Read More]

New data at EAN show Roche ’s OCREVUS (ocrelizumab) significantly reduced multiple measures of disease progression in relapsing and primary…

New data at EAN show Roche ’s OCREVUS (ocrelizumab) significantly reduced multiple measures of disease progression in relapsing and primary…

Roche announced today that new post-hoc analyses from the OCREVUS ™ (ocrelizumab) Phase III clinical trial programme [Read More]

MS Society Hosts Joint Congressional Briefing on the Value of Rehabilitation

MS Society Hosts Joint Congressional Briefing on the Value of Rehabilitation

/About-the-Society/News/Society-Hosts-Joint-Congressional-Briefing-on-the [Read More]